As of Feb 27
| -0.59 / -1.46%|
The 6 analysts offering 12-month price forecasts for Wuxi Pharmatech Cayman Inc have a median target of 43.25, with a high estimate of 45.00 and a low estimate of 38.00. The median estimate represents a +8.26% increase from the last price of 39.95.
The current consensus among 8 polled investment analysts is to Buy stock in Wuxi Pharmatech Cayman Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.